Lumophore Limited
06321509
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/07/2025
total exemption full
Next accounts due
30/04/2027
Confirmation statement
Last: 30/09/2025
Due 14/10/2026
Industry
Officers
director · Since 23/07/2007
DIRECTOR
BRITISH · ENGLAND · Age 55
Also on 10 other boards
Persons with Significant Control
Dr. Mohammad Farid Khan
British · England · Age 55
C/O Molgenics, Unit 25, Enterprise House, C/O Molgenics, Unit 25, Manchester, M15 6SE
Notified 06/04/2016
CompanyRankvs 7790+ SIC 72110 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£22k
Balance sheet strength
Cash
£22k
Cash in the bank
Net Current Assets
£35k
Working capital
Current Assets
£37k
Current Liabilities
£2k
Fixed Assets
£2k
Debtors
£15k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 20.62 | +£23k |
| 2024 | 15.74 | — |
| 2023 | 23.53 | — |
| 2022 | 23.94 | — |
| 2021 | 38.70 | -£5k |
| 2020 | 9.74 | +£7k |
| 2019 | 3.13 | -£186 |
| 2018 | 4.50 | — |
Derived from filed accounts. Not audited figures.